News | June 23, 2008

iCAD Purchases Assets of CAD Sciences

June 24, 2008 - iCAD Inc. signed a definitive agreement to purchase the principal assets of CAD Sciences, a privately-held medical technology company based in White Plains, N.Y, aiming to expand iCAD's portfolio to advanced image analysis and workflow solutions for the early detection of the most prevalent cancers including breast, colon, prostate and, in the future, lung cancer.

Under the terms of the agreement, iCAD will pay $2 million in cash and $3 million in shares of iCAD common stock. The number of shares issued will be calculated using the average closing price for the 10 consecutive trading days immediately preceding the closing. This synergistic business transaction is projected by iCAD to add approximately $500,000 to its quarterly operating expenses through the balance of 2008, and the transaction is expected to close early in the third quarter of 2008, subject to certain pre-closing conditions.

CAD Sciences develops and distributes pharmaco-kinetic based CAD products that aid in the interpretation of contrast enhanced Magnetic Resonance Imaging (MRI) images of the breast and prostate. Products are also under development by CAD Sciences for therapy monitoring, for the identification of vascular diseases using contrast enhanced Magnetic Resonance Angiography (MRA) and for cancer detection using contrast enhanced Computed Tomography (CT). CAD Sciences has established clinical relationships at hospitals and teaching institutions worldwide with installations at Duke University, Massachusetts General Hospital, Johns Hopkins Hospital, University of Nijmegen (The Netherlands), University of Vienna (Austria), and the Universities of Essen and Cologne (Germany).

The company also hopes to increass the potential of an expanded relationship with OEM partners who manufacture and market MRI systems through direct integration of these solutions, and augment its product-development initiatives for CT solutions for the early detection of colon and lung cancer.

For more information: www.icadmed.com

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Zebra Medical Vision Collaborating With Google Cloud on AI-Based Imaging Platform
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
PowerLook Tomo Detection Named 2017 New Hampshire High Technology Council Product of the Year
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
20/20 GeneSystems Launches AI-Based Lung Cancer Detection Technology in China
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...
Overlay Init